What adjuvant therapy would you offer a post-menopausal CHEK2+ patient with HR+ HER2+ T1bN1 breast cancer and concurrent HR+ HER2- T1N0 disease?  

I have a patient in her 60s with CHEK2 mutation, diagnosed with bilateral breast cancer. Lumpectomy showed b/l tumors <10mm both ER/PR+, HER2-, but one positive 11mm axillary sentinel node still ER/PR+, but HER2 is 3+.  



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Florida Cancer Specialists and Research Institute
In our hospital, we do not normally do separate ER...
Medical Oncologist at OSF HealthCare Saint Anthony Medical Center Center For Cancer Care
@Tarah Ballinger, would your approach change if th...
Sign in or Register to read more